Mariottoni, Eduardo B.
Jammal, Alessandro A.
Berchuck, Samuel I.
Shigueoka, Leonardo S.
Tavares, Ivan M.
Medeiros, Felipe A.
Funding for this research was provided by:
National Eye Institute (EY029885)
Article History
Received: 24 July 2020
Accepted: 29 December 2020
First Online: 18 January 2021
Competing interests
: FAM receives research support from Carl-Zeiss Meditec, Heidelberg Engineering, Google, Reichert and is a consultant for Allergan, Carl-Zeiss Meditec, Aeri Pharmaceuticals, Novartis, Biogen, Galimedix, Annexon, Stealth Biotherapeutics, Biozeus, Reichert and IDx. FAM also is an inventor/developer on a patent for NGoggle, Inc. IMT receives research support from Glaukos Corporation and lecture fees from Novartis and Alcon Pharmaceuticals. EBM, AAJ, SIB and LSS declare no potential competing interest.